1. Home
  2. METCB vs RGNX Comparison

METCB vs RGNX Comparison

Compare METCB & RGNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • METCB
  • RGNX
  • Stock Information
  • Founded
  • METCB 2015
  • RGNX 2008
  • Country
  • METCB United States
  • RGNX United States
  • Employees
  • METCB N/A
  • RGNX N/A
  • Industry
  • METCB Coal Mining
  • RGNX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • METCB Energy
  • RGNX Health Care
  • Exchange
  • METCB Nasdaq
  • RGNX Nasdaq
  • Market Cap
  • METCB 397.7M
  • RGNX 451.1M
  • IPO Year
  • METCB N/A
  • RGNX 2015
  • Fundamental
  • Price
  • METCB $18.91
  • RGNX $12.22
  • Analyst Decision
  • METCB Strong Buy
  • RGNX Strong Buy
  • Analyst Count
  • METCB 5
  • RGNX 8
  • Target Price
  • METCB $35.00
  • RGNX $28.50
  • AVG Volume (30 Days)
  • METCB 82.1K
  • RGNX 525.7K
  • Earning Date
  • METCB 11-03-2025
  • RGNX 11-05-2025
  • Dividend Yield
  • METCB 3.23%
  • RGNX N/A
  • EPS Growth
  • METCB N/A
  • RGNX N/A
  • EPS
  • METCB N/A
  • RGNX N/A
  • Revenue
  • METCB $625,919,000.00
  • RGNX $155,782,000.00
  • Revenue This Year
  • METCB N/A
  • RGNX $203.79
  • Revenue Next Year
  • METCB $24.16
  • RGNX $0.72
  • P/E Ratio
  • METCB N/A
  • RGNX N/A
  • Revenue Growth
  • METCB N/A
  • RGNX 74.95
  • 52 Week Low
  • METCB $5.95
  • RGNX $5.04
  • 52 Week High
  • METCB $20.58
  • RGNX $12.28
  • Technical
  • Relative Strength Index (RSI)
  • METCB 66.87
  • RGNX 64.52
  • Support Level
  • METCB $17.02
  • RGNX $10.24
  • Resistance Level
  • METCB $17.90
  • RGNX $11.00
  • Average True Range (ATR)
  • METCB 0.83
  • RGNX 0.51
  • MACD
  • METCB 0.10
  • RGNX 0.11
  • Stochastic Oscillator
  • METCB 100.00
  • RGNX 84.71

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About RGNX REGENXBIO Inc.

Regenxbio Inc is a biotechnology company. Its main activity is the development and commercialization of recombinant adeno associated virus gene therapy to correct an underlying genetic defect. The diseases that the Regenxbio platform targets are metabolic (homozygous familial hypercholesterolemia), neurodegenerative conditions (mucopolysaccharidosis), and retinal diseases (wet age-related macular degeneration, X-linked retinitis pigmentosa). The company derives the majority of its revenue from the United States.

Share on Social Networks: